Monitoring Asthma and COPD in Primary Care (Monaco)

• ClinicalTrials.gov Identifier: NCT00542061
• Recruitment Status: Completed
• First Posted: October 10, 2007
• Last Update Posted: March 9, 2010
• Sponsor: Radboud University Medical Center
• Collaborator: PICASSO: Partners in Care Solutions for COPD
• Information provided by: Radboud University Medical Center

Study Description

Brief Summary:

The purpose of this study is to determine the clinical effectiveness and cost-effectiveness of a written expert advice for GPs on additional diagnostic, treatment, and referral of patients based on half-yearly monitoring routines for patients with COPD or ashtma with a persistent obstruction in primary care based on a multicentre randomised nested clinical trial

Condition or disease	Intervention/treatment	Phase
Lung Diseases, Obstructive; Asthma	Device: half-yearly monitoring routine	Not Applicable

Detailed Description:

In the Netherlands, the majority of patients (60-80 %) with asthma or COPD are treated in primary care, primarily by General Practitioners (GPs). In 1995 a Regional Diagnostic Centre, Etten-Leur, The Netherlands (also called SHL: Stichting Huisartsen Laboratorium) started a lung function monitoring service for patients with asthma and COPD of GPs in the region. The GP receives recommendations on treatment, additional diagnostics and referrals of the patient based on extensive anamnesis (i.e. dyspnoea, symptoms, smoking stage), measurement of lung function, and BMI. Moreover,the general practitioners are supported by an Asthma/COPD nurse that visit the general practice half-yearly.

Main research question of this study: Is a written expert advice for GPs on additional diagnostic, treatment, and referral of patients based on half-yearly monitoring of patients with COPD or asthma with a persistent airway obstruction with support of an AC nurse consultant related to less impaired health related quality of life (HRQoL), less symptoms and better lung function of the patients compared to usual care?

A multi-centre, single blinded (patient, lung function assistant, advisor, and research team are blinded), parallel group study is carried out to compare the monitoring intervention with usual care during 24 months. General practices were allocated by a minimisation procedure and all participating patients of a general practice were allocated to the same treatment group (nested design).

Study Design

• Study Type: Interventional (Clinical Trial)
• Enrollment: 200 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Triple (Participant, Investigator, Outcomes Assessor)
• Primary Purpose: Supportive Care
• Official Title: Clinical Effectiveness and Cost-effectiveness of a Monitoring System for Patients With COPD and Asthma With Persistent Obstruction in Primary Care; a Multicentre Randomised Nested Clinical Trial
• Study Start Date: March 2005
• Actual Primary Completion Date: February 2007
• Actual Study Completion Date: April 2008

Arms and Interventions

Arm	Intervention/treatment
Experimental: A; Device: monitoring services	Device: half-yearly monitoring routine; A written expert advice for GPs on additional diagnostic, treatment, and referral of patients with asthma and COPD based on half-yearly monitoring routines (lung function assessments including extensive anamnese) supported by half-yearly visits of an AC nurse consultant to the general practices.
No Intervention: B; Control group: no monitoring procedures

Outcome Measures

Primary Outcome Measures :

1. Disease-specific health related quality of life assessed with the Chronic Respiratory Questionnaire (CRQ-SR) [ Time Frame: At baseline, after one year follow-up, and after two years follow-up ]

Secondary Outcome Measures :

1. Number of exacerbations; generic HRQoL (SF12); lung function indices; level of respiratory symptoms (MRC); satisfaction with the health care received (EuroPep); direct and indirect medical costs. [ Time Frame: Yearly: SF12, MRC, exacerbations; At baseline and end of the trial: EuroPEP, lung function indices; Continues by general practitioner registration: costs and exacerbations ]
2. Moreover special attention will be paid to process evaluation (e.g, compliance to recommendations by general practitioner and patients). [ Time Frame: half-yearly for general practitioners and yearly for patients ]

Eligibility Criteria

• Ages Eligible for Study: 25 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• The patient is categorised as asthmatic disease with persistent airway obstruction or COPD in the monitoring system SHL confirmed by the most recent lung function assessment (FEV1/FVC < 70% after BD and FEV1 ≥ 50% pred after BD) or (FEV1 < 80% predicted after BD and ≥ 9% reversibility)
• The patient is monitored by the AC service of the SHL.
• The GP of the patient is willing to participate in the trial.
• Written informed consent of participant

Exclusion Criteria:

• Patients treated primary by a pulmonologist
• Patients currently participating in another respiratory intervention study
• When the GP considers it detrimental to the patient to participate in the study
• Serious other non-pulmonary diseases (or disease-stages) that are presumed to lead to "lost to follow-up" because of the severity of the disease course (like diseases with low survival rate or mental deterioration)
• Serious other pulmonary diseases that effect bronchial symptoms and/or lung function, e.g. sarcoidosis, lung cancer, lung fibrosis
• Illiteracy

Contacts and Locations

Locations

Netherlands

Regional Diagnostic Centre, Etten-Leur, The Netherlands (SHL)

Etten-Leur, Netherlands

Sponsors and Collaborators

Radboud University Medical Center

PICASSO: Partners in Care Solutions for COPD

Investigators

• Study Director: Tjard Schermer, PhD; Radboud University Nijmegen Medical Centre, department of general practice
• Principal Investigator: Lisette van den Bemt, MSc; Radboud University Nijmegen Medical Centre, department of general practice
• Study Chair: Chris van Weel, MD PhD professor; Radboud University Nijmegen Medical Centre, department of general practice

More Information

Additional Information:

Website Radboud University Nijmegen Medical Centre 

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

van den Bemt L, Schermer TR, Smeele IJ, Boonman-de Winter LJ, van Boxem T, Denis J, Grootens-Stekelenburg JG, Grol RP, van Weel C. An expert-supported monitoring system for patients with chronic obstructive pulmonary disease in general practice: results of a cluster randomised controlled trial. Med J Aust. 2009 Sep 7;191(5):249-54.

• ClinicalTrials.gov Identifier: NCT00542061
• Other Study ID Numbers: Picasso 04-008
• First Posted: October 10, 2007
• Last Update Posted: March 9, 2010
• Last Verified: October 2007

Keywords provided by Radboud University Medical Center:

COPD; Asthma; Lung function; Monitoring; Primary Care

Additional relevant MeSH terms:

Asthma; Lung Diseases; Lung Diseases, Obstructive; Bronchial Diseases; Respiratory Tract Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases